Department of Justice 2008 – Federal Register Recent Federal Regulation Documents

Results 551 - 600 of 818
Solicitation for a Cooperative Agreement-Video Production: New Jail Planning
Document Number: E8-9448
Type: Notice
Date: 2008-04-30
Agency: Department of Justice, National Institute of Corrections
The National Institute of Corrections (NIC), Jails Division, is seeking applications for the development and production of a broadcast quality, educational DVD covering the five phases of new jail planning.
Classification of Three Steroids as Schedule III Anabolic Steroids Under the Controlled Substances Act
Document Number: E8-8842
Type: Proposed Rule
Date: 2008-04-25
Agency: Drug Enforcement Administration, Department of Justice
This Notice of Proposed Rulemaking (NPRM) proposes to classify the following three steroids as ``anabolic steroids'' under the Controlled Substances Act (CSA): boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione. The Drug Enforcement Administration (DEA) believes that this action is necessary in order to prevent the abuse and trafficking of these steroids. If the regulations are amended, these steroids will be listed as schedule III controlled substances subject to the regulatory control provisions of the CSA.
Notice of Lodging Proposed Consent Decree
Document Number: E8-8647
Type: Notice
Date: 2008-04-23
Agency: Department of Justice
Child Nutrition Programs-Income Eligibility Guidelines
Document Number: Z8-7475
Type: Notice
Date: 2008-04-21
Agency: Department of Agriculture, Department of Defense, Internal Revenue Service, Department of Treasury, Department of Justice, Merit Systems Protection Board, Agencies and Commissions, Department of the Navy, Department of the Treasury, Food Nutrition Service, Food and Nutrition Service
Notice of Lodging Proposed Consent Decree
Document Number: Z8-7270
Type: Notice
Date: 2008-04-21
Agency: Department of Justice
DNA-Sample Collection Under the DNA Fingerprint Act of 2005 and the Adam Walsh Child Protection and Safety Act of 2006
Document Number: E8-8339
Type: Proposed Rule
Date: 2008-04-18
Agency: Department of Justice
The Department of Justice is publishing this proposed rule to implement amendments made by section 1004 of the DNA Fingerprint Act of 2005 and section 155 of the Adam Walsh Child Protection and Safety Act of 2006 to section 3 of the DNA Analysis Backlog Elimination Act of 2000. This rule directs agencies of the United States that arrest or detain individuals, or that supervise individuals facing charges, to collect DNA samples from individuals who are arrested, facing charges, or convicted, and from non-United States persons who are detained under the authority of the United States. Unless otherwise directed by the Attorney General, the collection of DNA samples may be limited to individuals from whom an agency collects fingerprints. The Attorney General also may approve other limitations or exceptions. Agencies collecting DNA samples are directed to furnish the samples to the Federal Bureau of Investigation, or to other agencies or entities as authorized by the Attorney General, for purposes of analysis and entry into the Combined DNA Index System.
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E8-8279
Type: Notice
Date: 2008-04-17
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E8-8275
Type: Notice
Date: 2008-04-17
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E8-8180
Type: Notice
Date: 2008-04-16
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: E8-8177
Type: Notice
Date: 2008-04-16
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E8-8176
Type: Notice
Date: 2008-04-16
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E8-8165
Type: Notice
Date: 2008-04-16
Agency: Drug Enforcement Administration, Department of Justice
Columbia Gas Transmission Corporation; Notice of Request for Permission to Withdraw Tariff Filing
Document Number: Z8-5252
Type: Notice
Date: 2008-04-14
Agency: Antitrust Division, Department of Justice, Department of Energy, Federal Energy Regulatory Commission
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E8-7822
Type: Notice
Date: 2008-04-11
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, Alcohol, Tobacco, Firearms, and Explosives Bureau
Meeting of the Compact Council for the National Crime Prevention and Privacy Compact
Document Number: E8-7616
Type: Notice
Date: 2008-04-11
Agency: Federal Bureau of Investigation, Department of Justice
The purpose of this notice is to announce a meeting of the National Crime Prevention and Privacy Compact Council (Council) created by the National Crime Prevention and Privacy Compact Act of 1998 (Compact). Thus far, the Federal Government and 27 states are parties to the Compact which governs the exchange of criminal history records for licensing, employment, and similar purposes. The Compact also provides a legal framework for the establishment of a cooperative federal-state system to exchange such records. The United States Attorney General appointed 15 persons from federal and state agencies to serve on the Council. The Council will prescribe system rules and procedures for the effective and proper operation of the Interstate Identification Index System. Matters for discussion are expected to include: (1) Compact Council Fingerprint Requirements Rule. (2) Hurricane Katrina Experience Report. (3) Outsourcing of Noncriminal Justice Administrative Functions. The meeting will be open to the public on a first-come, first- seated basis. Any member of the public wishing to file a written statement with the Council or wishing to address this session of the Council should notify Mrs. Paula A. Barron at (304) 625-2749, at least 24 hours prior to the start of the session. The notification should contain the requestor's name and corporate designation, consumer affiliation, or government designation, along with a short statement describing the topic to be addressed and the time needed for the presentation. Requesters will ordinarily be allowed up to 15 minutes to present a topic. Dates and Times: The Council will meet in open session from 9 a.m. until 5 p.m., on May 14-15, 2008.
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E8-7080
Type: Notice
Date: 2008-04-11
Agency: Drug Enforcement Administration, Department of Justice
Notice of Lodging Proposed Consent Decree
Document Number: E8-7520
Type: Notice
Date: 2008-04-10
Agency: Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E8-7518
Type: Notice
Date: 2008-04-10
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, Alcohol, Tobacco, Firearms, and Explosives Bureau
Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance
Document Number: E8-7391
Type: Proposed Rule
Date: 2008-04-09
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is proposing to designate the precursor chemical, 4-anilino-N-phenethyl-4-piperidine (ANPP) as an immediate precursor for the schedule II controlled substance, fentanyl, under the definition set forth in 21 U.S.C. Sec. 802(23). Furthermore, DEA is proposing to control ANPP as a schedule II substance under the Controlled Substances Act (CSA), pursuant to the authority in 21 U.S.C. 811(e), which states that an immediate precursor may be placed in the same schedule as the controlled substance it produces, without the need of addressing the ``factors determinative of control'' in 21 U.S.C. Sec. 811 or the findings required in 21 U.S.C. 812(b). ANPP is the immediate chemical intermediary in the synthesis process currently used by clandestine laboratory operators for the illicit manufacture of the schedule II controlled substance fentanyl. The distribution of illicitly manufactured fentanyl has caused an unprecedented outbreak of hundreds of fentanyl-related overdoses in the United States in recent months. DEA believes that the control of ANPP as a schedule II controlled substance is necessary to prevent its diversion as an immediate chemical intermediary for the illicit production of fentanyl.
Notice of Lodging Proposed Consent Decree
Document Number: E8-7270
Type: Notice
Date: 2008-04-09
Agency: Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E8-7327
Type: Notice
Date: 2008-04-08
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, Alcohol, Tobacco, Firearms, and Explosives Bureau
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E8-7325
Type: Notice
Date: 2008-04-08
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, Alcohol, Tobacco, Firearms, and Explosives Bureau